MedPath

Mechanisms of Anaphylaxis

Active, not recruiting
Conditions
Anaphylaxis
Febrile Transfusion Reaction
Allergy
Transfusion Reaction
Registration Number
NCT03182491
Lead Sponsor
Haukeland University Hospital
Brief Summary

The purpose of this study is to explore different mechanisms for anaphylaxis and find novel biomarkers for this hypersensitivity syndrome. The study participants are patients with anaphylaxis, patients with mild allergic reactions, and patients with febrile transfusion reactions. The investigators will also include a group of healthy controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

According to the specific cohort:

  1. Diagnosis of anaphylaxis
  2. Mild allergic reaction
  3. Febrile transfusion reaction
  4. Healthy, no known allergic disease
Exclusion Criteria

Suspicion or diagnosed sepsis Children

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clarify mechanisms for anaphylaxis and establish biomarkers for this syndrome2 days

Immunological/nonimmunological mechanism

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Haukeland University Hospital

🇳🇴

Bergen, Norway

Haukeland University Hospital
🇳🇴Bergen, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.